Neuren Pharmaceuticals Ltd. (NURPF)
16.10
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Neuren Pharmaceuticals Market Cap : 2.041B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 2.041B |
| September 04, 2026 | 2.041B |
| September 03, 2026 | 2.041B |
| September 02, 2026 | 2.041B |
| September 01, 2026 | 2.030B |
| August 31, 2026 | 2.030B |
| August 28, 2026 | 2.059B |
| August 27, 2026 | 2.059B |
| August 26, 2026 | 1.966B |
| August 25, 2026 | 1.966B |
| August 24, 2026 | 1.966B |
| August 21, 2026 | 1.966B |
| August 20, 2026 | 1.964B |
| August 19, 2026 | 1.964B |
| August 18, 2026 | 1.964B |
| August 17, 2026 | 2.052B |
| August 14, 2026 | 2.153B |
| August 13, 2026 | 2.153B |
| August 12, 2026 | 2.153B |
| August 11, 2026 | 2.153B |
| August 10, 2026 | 2.026B |
| August 07, 2026 | 1.900B |
| August 06, 2026 | 1.900B |
| August 05, 2026 | 1.705B |
| August 04, 2026 | 1.705B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.705B |
| July 31, 2026 | 1.705B |
| July 30, 2026 | 1.705B |
| July 29, 2026 | 1.705B |
| July 28, 2026 | 1.705B |
| July 27, 2026 | 1.705B |
| July 24, 2026 | 1.705B |
| July 23, 2026 | 1.705B |
| July 22, 2026 | 1.705B |
| July 21, 2026 | 1.705B |
| July 20, 2026 | 1.705B |
| July 17, 2026 | 1.705B |
| July 16, 2026 | 1.705B |
| July 15, 2026 | 1.705B |
| July 14, 2026 | 1.705B |
| July 13, 2026 | 1.705B |
| July 10, 2026 | 1.705B |
| July 09, 2026 | 1.705B |
| July 08, 2026 | 1.705B |
| July 07, 2026 | 1.705B |
| July 06, 2026 | 1.705B |
| July 02, 2026 | 1.705B |
| July 01, 2026 | 1.705B |
| June 30, 2026 | 1.705B |
| June 29, 2026 | 1.174B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Percheron Therapeutics Ltd. | 3.654M |
| Starpharma Holdings Ltd. | 250.60M |
| Mayne Pharma Group Ltd. | 190.93M |
| Acrux Ltd. | 1.725M |
| Zelira Therapeutics Ltd. | 3.093M |
Market Cap Related Metrics
| PE Ratio | 156.31 |
| PS Ratio | 44.38 |
| Price to Free Cash Flow | 327.50 |
| Price | 16.10 |
| Earnings Yield | 0.64% |
| Operating PE Ratio | 227.22 |
| Normalized PE Ratio | 130.36 |